Contact Us

19000 33rd Ave W.
Suite 130
Lynnwood, WA 98036-4753
United States
PR Contact
Chris Joseph
(510) 435-4031

More »

Volpara Solutions Features AI-Powered Cancer Screening Platform at RSNA

Volpara Solutions has joined with MRS Systems and ScreenPoint Medical to provide radiologists the clinical decision support and practice management tools they need to detect cancer earlier.

Clinical Decision Support. The newly redesigned Volpara®Scorecard+™ provides radiologists with easy access to three key patient risk insights: breast density assessment, an indication of suspicious findings in the mammogram, and lifetime risk of developing breast cancer. With accurate, actionable information about each patient available right from their workstation, radiologists can make an informed and timely decision about the patient’s need for supplemental imaging and/or genetic testing as part of a personalized breast care plan.

Practice Management. Together, Aspen Breast and Volpara®Enterprise software provide patient, workflow, and image-quality analytics to help managers improve quality and maximize resource utilization.

News Releases
Dec 2, 2019

CHICAGO, December 2, 2019 – Volpara Solutions, Inc., showcases its end-to-end breast cancer screening workflow at the 105th Annual Radiological Society of North America (RSNA) meeting, December 1–

Nov 26, 2019

CHICAGO, November 26, 2019 – Volpara Solutions, Inc., will showcase its Cancer Screening Platform, powered by artificial intelligence (AI), at the 105th Annual Radiological Society of North America (RSNA) meeting, December 1–6, 2019 (South Hall #4770). Volpara Solutions has joined forces with MRS Systems and ScreenPoint Medical to provide radiologists with the clinical decision-support tools they need to personalize breast screening for early cancer detection.

Oct 24, 2019

Wellington, NZ, October 24, 2019: Volpara Solutions, an industry leader in cancer screening workflow, today announced the expansion of its global Medical Advisory Board. Comprised of leading breast imaging experts and researchers from around the world, the Medical Advisory Board members will provide external clinical and scientific expertise to advance Volpara’s mission to help each breast care team detect cancers earlier.

Jul 23, 2019

Wellington, NZ, July 23, 2019 – Volpara Solutions and ScreenPoint Medical BV today announced signature of an agreement under which Volpara will sell ScreenPoint’s Transpara™ products to breast imaging clinics in the United States, Australia, New Zealand, and parts of Asia. Transpara is designed to assist radiologists with the reading of mammograms and is one of the first next-generation artificial intelligence (AI) applications for detecting breast cancer in screening mammograms to gain 510(k) clearance from the US Food & Drug Administration (FDA).

Jul 9, 2019

SEATTLE, July 9, 2019 - Swedish Health Services and Volpara Solutions today announced the implementation of Volpara®Enterprise™ software at its network of breast care centers. Swedish, an affiliate of Providence St. Joseph’s Health, performs more than 75,000 mammograms annually at its distributed network of facilities in the Seattle region. In addition to its 10 locations, the program also includes two mobile mammography coaches that service the greater Puget Sound region.

More »